Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjögren's syndrome

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2010-03-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2009.122903PMID 20215141PMCID PMC2920370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic regulation and the pathogenesis of systemic lupus erythematosus.

  2009cited by this paper
• Replication of recently identified systemic lupus erythematosus genetic associations: a case–control study

  2009cited by this paper
• Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus.

  2009cited by this paper
• Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients

  2008cited by this paper
• Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus

  2008cited by this paper
• Genes and Sjögren's syndrome.

  2008cited by this paper
• Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus‐prone mice

  2007cited by this paper
• EuropeanStudy Group on Classification Criteria for Sjögren's Syndrome. Classificationcriteria for Sjögren's syndrome: a revised version of the European criteriaproposed by the American-European Consensus Group

  2002cited by this paper
• Genetic aspects of Sjögren's syndrome

  2002cited by this paper
• Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

  2002cited by this paper
• The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome.

  1992cited by this paper
• The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome

  1990cited by this paper

• BIOCHEMICAL AND MOLECULAR DETERMINANTS OF THE SUBCLINICAL INFLAMMATORY MECHANISMS IN RETT SYNDROME.

  2024cites this paper
• Circular RNA CircDHRS3 Aggravates IL-1β-induced ECM Degradation, Apoptosis, and Inflammatory Response via Mediating MECP2 Expression

  2023cites this paper
• Abnormal Epigenetic Regulations in the Immunocytes of Sjögren’s Syndrome Patients and Therapeutic Potentials

  2022cites this paper
• [Sjögren's syndrome].

  2021cites this paper
• MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge

  2021cites this paper
• Long non-coding RNA expression profiles identify lncRNA-XLOC_I2_006631 as a potential novel blood biomarker for Hashimoto's thyroiditis

  2020cites this paper
• Cortisol profiles and clinical severity in MECP2 duplication syndrome

  2020cites this paper
• MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge: implications for Rett Syndrome

  2020cites this paper
• Sjögren’s Syndrome

  2019cites this paper
• Genetics and epigenetics in primary Sjögren’s syndrome

  2019cites this paper
• Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis

  2018cites this paper
• Update on Pathogenesis of Sjogren's Syndrome.

  2017cites this paper
• Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.

  2017cites this paper
• Genetics, Genomics, Gene Expression Profiling, and Epigenetics in Sjögren’s Syndrome

  2016cites this paper
• Diurnal Salivary Cortisol and Regression Status in MECP2 Duplication Syndrome

  2016cites this paper
• Genetics of systemic lupus erythematosus and Sjögren's syndrome: an update

  2016cites this paper
• Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective.

  2016cites this paper
• Unexpected cellular players in Rett syndrome pathology.

  2016cites this paper
• Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs

  2015cites this paper
• Methyl CpG binding protein 2 deficiency enhances expression of inflammatory cytokines by sustaining NF-κB signaling in myeloid derived cells.

  2015cites this paper
• Genome‐Wide DNA Methylation Patterns in Naive CD4+ T Cells From Patients With Primary Sjögren's Syndrome

  2014cites this paper
• Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis.

  2014cites this paper
• MeCP2 enforces Foxp3 expression to promote regulatory T cells’ resilience to inflammation

  2014cites this paper
• MeCP2 Reinforces STAT3 Signaling and the Generation of Effector CD4+ T Cells by Promoting miR-124–Mediated Suppression of SOCS5

  2014cites this paper
• DNA Modifications: Function and Applications in Normal and Disease States

  2014cites this paper
• Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis.

  2013cites this paper
• Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse.

  2013cites this paper
• New insight on the Xq28 association with systemic sclerosis

  2013cites this paper
• Faculté de Médecine Contribution to the diagnosis and pathophysiology of Sjögren’s Syndrome

  2013cites this paper
• Alterations in type I hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with Sjögren's syndrome.

  2011cites this paper
• MEDICAL MANAGEMENT AND PHARMACOLOGY UPDATE

  2011cites this paper
• Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.

  2011cites this paper
• Primary Sjögren’s syndrome: current pathophysiological, diagnostic and therapeutic advances

  2011cites this paper
• Pathogenesis of Sjögren's syndrome and therapeutic consequences

  2010cites this paper